artenimol has been researched along with prolinedithiocarbamate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TD; Cao, Z; Deng, X; Dong, F; Li, C; Li, L; Liu, J; Tang, B; Yan, S; Zhou, X | 1 |
1 other study(ies) available for artenimol and prolinedithiocarbamate
Article | Year |
---|---|
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Artemisinins; Binding Sites; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Physiologic; NF-kappa B; Nucleotide Motifs; Proline; Promoter Regions, Genetic; Protein Binding; Retina; Retinal Vessels; Signal Transduction; Thiocarbamates; Transcription Factor RelA; Transcriptional Activation; Vascular Endothelial Growth Factor Receptor-2 | 2014 |